Plus Therapeutics (PSTV) Misses Q3 EPS by 37c

Plus Therapeutics (NASDAQ: PSTV) reported Q3 EPS of ($0.37). Revenue for the quarter came in at $1.45 million.

For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• La-Z-Boy (LZB) Misses Q1 EPS by 6c, Misses on Revenue; Offers Weak Q2 Revenue Guidance
• UBS Downgrades Core Natural Resources (CNR) to Neutral